Screening for colorectal cancer in elderly persons: who should we screen and when can we stop?
OBJECTIVE
The aim of this study was to quantify the impact of age on the potential benefits of screening for colorectal cancer.


METHODS
Life-table analysis of the risks of dying from colorectal cancer or from all other causes was performed. The impact of prematurely stopping screening was compared to the maximal potential benefit expected from lifelong screening.


RESULTS
The relative proportion of deaths from colorectal cancer compared to all other causes was greatest at the age of 62 and diminished thereafter. A total of 80% of the maximal benefit from screening was achieved by screening till the age of 82. The impact of prematurely stopping screening varied with gender and race.


CONCLUSIONS
The maximal societal benefit will be achieved by screening at younger ages because of competing causes of mortality among older people. Gender and ethnicity should be considered in individual decisions to stop screening at a given age.
Maheshwari
Shail
S
Baylor College of Medicine, USA.
Patel
Tushar
T
Patel
Parita
P
D000368:Aged; D000369:Aged, 80 and over; D044383:Black People; D015179:Colorectal Neoplasms / Q000401:mortality / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000706:statistics & numerical data; D012737:Sex Factors; D014481:United States; D044465:White People; D001741:Black or African American